Kuvalanka brings over 20 years of experience in biopharmaceutical leadership, including finance, business development, and corporate strategy.

Agreement includes approximately $350 million in cash and upfront technology license fees for Evotec’s continuous manufacturing platform.

Ailux has announced a strategic collaboration with Eli Lilly and Company to accelerate the discovery and development of bispecific antibodies.

The research collaboration agreement will offer new chemical entity (NCE)-eligible pro-drug candidates to people affected by blinding eye conditions.

Simtra BioPharma Solutions is advancing a dual-continent expansion aimed at boosting capacity for sterile injectable drugs.

To develop monoclonal antibody biomanufacturing innovations and produce an anti-filovirus Medical Countermeasure.

Merck has reached an agreement with Dr. Falk Pharma to discontinue an existing contract concerning co-development and co-commercialization rights in certain territories for MK-8690.